Cardiovascular activity of some substituted 2-aminobenzoquinolizines.
D000284:Administration, Oral; D000588:Amines / Q000138:chemical synthesis / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D003326:Coronary Circulation / Q000187:drug effects; D004285:Dogs; D006339:Heart Rate / Q000187:drug effects; D007259:Infrared Rays; D007275:Injections, Intravenous; D007536:Isomerism; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D011807:Quinolizines / Q000138:chemical synthesis* / Q000494:pharmacology; D013057:Spectrum Analysis; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000138:chemical synthesis* / Q000494:pharmacology
D000588:Amines; D000959:Antihypertensive Agents; D011807:Quinolizines; D014665:Vasodilator Agents